Mobius Therapeutics, LLC Email Format
Pharmaceutical ManufacturingMissouri, United States2-10 Employees
Mobius Therapeutics, LLC is a pharmaceutical manufacturer focused on ophthalmic care. Its flagship product, Mitosol, received FDA approval in 2012 and is positioned as a standard for preparing and delivering mitomycin-C in the ophthalmic operating room, addressing the need for reliable, regulated solutions in eye surgery. The company emphasizes designing its products from the outset to meet the sterile and operational requirements of the ophthalmic OR, aiming to reduce reliance on off-label or inconvenient compounded formulations. Based in St. Louis, Missouri, Mobius has a small team and operates within the broader ophthalmic and pharmaceutical manufacturing landscape. The organization seeks to expand its portfolio through ongoing product development and regulatory efforts, with a stated goal of collaborating with the ophthalmic community to address perioperative needs. A notable recent development cited is a collaboration with Leiters to supply Mitosol, underscoring its focus on ensuring supply continuity for its customers.